These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 23922106)
1. Proline-rich tyrosine kinase 2 and its phosphorylated form pY881 are novel prognostic markers for non-small-cell lung cancer progression and patients' overall survival. Kuang BH; Zhang MQ; Xu LH; Hu LJ; Wang HB; Zhao WF; Du Y; Zhang X Br J Cancer; 2013 Sep; 109(5):1252-63. PubMed ID: 23922106 [TBL] [Abstract][Full Text] [Related]
2. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis. Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507 [TBL] [Abstract][Full Text] [Related]
3. The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas. Li F; Zeng H; Ying K Med Oncol; 2011 Dec; 28(4):1458-62. PubMed ID: 20717756 [TBL] [Abstract][Full Text] [Related]
4. SOCS3 expression is inversely correlated with Pyk2 in non-small cell lung cancer and exogenous SOCS3 inhibits proliferation and invasion of A549 cells. Zhang S; Wang W; Wang E; Qiu X Pathology; 2012 Aug; 44(5):434-40. PubMed ID: 22722483 [TBL] [Abstract][Full Text] [Related]
5. Expression of ABCG2 and Bmi-1 in oral potentially malignant lesions and oral squamous cell carcinoma. Dalley AJ; Pitty LP; Major AG; Abdulmajeed AA; Farah CS Cancer Med; 2014 Apr; 3(2):273-83. PubMed ID: 24415717 [TBL] [Abstract][Full Text] [Related]
6. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome. Li X; Wan L; Geng J; Wu CL; Bai X J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249 [TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy. Shien K; Toyooka S; Ichimura K; Soh J; Furukawa M; Maki Y; Muraoka T; Tanaka N; Ueno T; Asano H; Tsukuda K; Yamane M; Oto T; Kiura K; Miyoshi S Lung Cancer; 2012 Jul; 77(1):162-7. PubMed ID: 22387005 [TBL] [Abstract][Full Text] [Related]
8. Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer. Raz G; Allen KE; Kingsley C; Cherni I; Arora S; Watanabe A; Lorenzo CD; Edwards V DK; Sridhar S; Hostetter G; Weiss GJ Lung Cancer; 2012 May; 76(2):191-6. PubMed ID: 22115706 [TBL] [Abstract][Full Text] [Related]
9. All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells. Yao W; Wang L; Huang H; Li X; Wang P; Mi K; Cheng J; Liu H; Gu C; Huang L; Huang J BMC Cancer; 2020 Apr; 20(1):315. PubMed ID: 32293355 [TBL] [Abstract][Full Text] [Related]
10. Expression and functional analyses of breast cancer resistance protein in lung cancer. Kawabata S; Oka M; Soda H; Shiozawa K; Nakatomi K; Tsurutani J; Nakamura Y; Doi S; Kitazaki T; Sugahara K; Yamada Y; Kamihira S; Kohno S Clin Cancer Res; 2003 Aug; 9(8):3052-7. PubMed ID: 12912956 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancer. Zhang S; Qiu X; Gu Y; Wang E Lung Cancer; 2008 Dec; 62(3):295-301. PubMed ID: 18571765 [TBL] [Abstract][Full Text] [Related]
12. Kruppel-like factor 5 is not required for K-RasG12D lung tumorigenesis, but represses ABCG2 expression and is associated with better disease-specific survival. Meyer SE; Hasenstein JR; Baktula A; Velu CS; Xu Y; Wan H; Whitsett JA; Gilks CB; Grimes HL Am J Pathol; 2010 Sep; 177(3):1503-13. PubMed ID: 20639455 [TBL] [Abstract][Full Text] [Related]
13. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer. Kahlert C; Bergmann F; Beck J; Welsch T; Mogler C; Herpel E; Dutta S; Niemietz T; Koch M; Weitz J BMC Cancer; 2011 Jun; 11():275. PubMed ID: 21708005 [TBL] [Abstract][Full Text] [Related]
14. The effects of artesunate on the expression of EGFR and ABCG2 in A549 human lung cancer cells and a xenograft model. Ma H; Yao Q; Zhang AM; Lin S; Wang XX; Wu L; Sun JG; Chen ZT Molecules; 2011 Dec; 16(12):10556-69. PubMed ID: 22183882 [TBL] [Abstract][Full Text] [Related]
15. [Expression of SOCS3 and Pyk2 and their correlation in non-small cell lung cancer]. Zhang SY; Qiu XS Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):657-61. PubMed ID: 23302305 [TBL] [Abstract][Full Text] [Related]
16. TrkB is highly expressed in NSCLC and mediates BDNF-induced the activation of Pyk2 signaling and the invasion of A549 cells. Zhang S; Guo D; Luo W; Zhang Q; Zhang Y; Li C; Lu Y; Cui Z; Qiu X BMC Cancer; 2010 Feb; 10():43. PubMed ID: 20156366 [TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer. Alamgeer M; Ganju V; Szczepny A; Russell PA; Prodanovic Z; Kumar B; Wainer Z; Brown T; Schneider-Kolsky M; Conron M; Wright G; Watkins DN Thorax; 2013 Dec; 68(12):1095-104. PubMed ID: 23878161 [TBL] [Abstract][Full Text] [Related]
18. Expressions of topoisomerase IIα and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patients. Rijavec M; Silar M; Triller N; Kern I; Cegovnik U; Košnik M; Korošec P Pathol Oncol Res; 2011 Sep; 17(3):691-6. PubMed ID: 21455636 [TBL] [Abstract][Full Text] [Related]
19. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer. Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393 [TBL] [Abstract][Full Text] [Related]